The name of the game is volume. The more volume a drug company has with a particular PBM, and the greater the drug company's market share, the better the potential deal that the drug company can offer as an inducement to disfavor rival drugs.
Warren discusses how PBMs create incentives that favor larger drug companies over competitors.
Share
More from Elizabeth Warren
The nurses at Brigham and Women’s Hospital have demonstrated their willingness to continue negotiating with Mass General Brigham leadership to arrive at an agreement that works for nurses, patients, and our hospitals.
It's supposed to be out there regulating the market, but it doesn't appear to be doing it and frankly, doesn't appear to have the people to do it.
Inflation data came in, and Donald Trump’s failed economic agenda has raised prices for Americans by 5.9%.
Other voices in this conversation
